Fig. 5
From: A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer
Developing and validation of TP53-associated prognostic signature. a Tuning parameter (lambda) in the LASSO regression analysis. b Dynamic coefficient profiling of the LASSO regression analysis. c The hazard ratios (HRs) in the stepwise regression analysis. d Kaplan-Meier curve of the training cohort. e Kaplan-Meier curve of the external validation cohort. f The 1-, 2-, 3-, 4-, and 5-year ROC curves of the training cohort. g The 1-, 2-, 3-, 4-, and 5-year ROC curves of the external validation cohort. P < 0.05 indicated statistically significant